State Of Wisconsin Investment Board Viridian Therapeutics, Inc.\De Transaction History
State Of Wisconsin Investment Board
- $36.3 Billion
- Q1 2024
A detailed history of State Of Wisconsin Investment Board transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 22,270 shares of VRDN stock, worth $289,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,270
Previous 58,325
61.82%
Holding current value
$289,732
Previous $1.27 Million
69.37%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VRDN
# of Institutions
143Shares Held
62.1MCall Options Held
160KPut Options Held
354K-
Paradigm Biocapital Advisors LP New York, NY5.03MShares$65.5 Million3.3% of portfolio
-
State Street Corp Boston, MA4.49MShares$58.4 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$50.5 Million5.84% of portfolio
-
Black Rock Inc. New York, NY3.81MShares$49.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.66MShares$47.6 Million1.34% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $519M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...